Foghorn Therapeutics Inc. reports financial results in SEC 8-K

Foghorn Therapeutics Inc. filed an 8-K covering results of operations or financial condition and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.